Biotech scan­dal drags on as the feds on­ly score par­tial vic­to­ry against ex­ecs charged with cook­ing the books

More than three years af­ter the SEC first charged for­mer ex­ec­u­tives of Osiris Ther­a­peu­tics for cook­ing the books, the le­gal saga still isn’t over just yet.

The feds had sought par­tial sum­ma­ry judg­ment — which would al­low them to skip tri­al and go straight in­to a ver­dict — against Lode De­bra­ban­dere and Philip Ja­co­by, who held the CEO and CFO posts, re­spec­tive­ly. While a Mary­land judge most­ly sided with them, he ruled that the SEC has not gone far enough to prove all the claims.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER